Northpond Ventures 13F annual report

Northpond Ventures is an investment fund managing more than $34.7 billion ran by Patrick Smerkers. There are currently 3 companies in Mr. Smerkers’s portfolio. The largest investments include Vigil Neuroscience Inc and Telesis Bio Inc, together worth $33 billion.

$34.7 billion Assets Under Management (AUM)

As of 7th November 2023, Northpond Ventures’s top holding is 4,214,498 shares of Vigil Neuroscience Inc currently worth over $22.7 billion and making up 65.4% of the portfolio value.In addition, the fund holds 9,844,130 shares of Telesis Bio Inc worth $10.2 billion, whose value fell approximately 0.1% in the past six months. The third-largest holding is Candel Therapeutics Inc worth $1.78 billion.

Currently, Northpond Ventures's portfolio is worth at least $34.7 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Northpond Ventures

The Northpond Ventures office and employees reside in Bethesda, Maryland. According to the last 13-F report filed with the SEC, Patrick Smerkers serves as the CFO, Partner at Northpond Ventures.